-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
Daclatasvir-d16
![{PARAM:[Name]}({[CAS]})](https://resource.bocsci.com/structure/daclatasvir-d16.gif)
| Category | Hepatitis C Virus (HCV) |
| Description | Daclatasvir-d16 is a labelled Daclatasvir which inhibits the HCV protein NS5A, and thus can be used as a drug candidate for the treatment of hepatitis C (HCV). |
Product Information
| Synonyms | BMS-790052-d16; EBP 883-d16 |
| Molecular Weight | 754.97 |
| Molecular Formula | C40H34D16N8O6 |
| Canonical SMILES | O=C(C(NC(OC)=O)([2H])C([2H])(C([2H])([2H])[2H])C([2H])([2H])[2H])N1CCC[C@H]1C2=NC=C(N2)C3=CC=C(C=C3)C4=CC=C(C5=CN=C([C@@H]6CCCN6C(C(NC(OC)=O)([2H])C([2H])(C([2H])([2H])[2H])C([2H])([2H])[2H])=O)N5)C=C4 |
| Boiling Point | 1071.2±65.0 °C at 760 mmHg |
| Flash Point | 601.7±34.3 °C |
| Purity | > 95% |
| Density | 1.3±0.1 g/cm3 |
| Solubility | DMSO: soluble Methanol: soluble |
| Appearance | Solid powder |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Complexity | 1190 |
| Exact Mass | 754.48575928 |
| Index Of Refraction | 1.595 |
| In Vitro | Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and Metabolic profiles of drugs. |
| Target | HCV |
| Vapor Pressure | 0.0±0.3 mmHg at 25°C |
| XLogP3-AA | 5.1 |